Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (841-850 of 874) with videos related to

Pageof 88
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1983
In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distributionR M Arendt, D J Greenblatt, R H deJong, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Alprazolam-ritonavir interaction: implications for product labelingD J Greenblatt, L L von Moltke, J S Harmatz, et al.
Neurology|April 1, 1983
Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactionsT R Browne, R G Feldman, R A Buchanan, et al.
Molecular Cell|August 13, 1999
An unusual eukaryotic protein phosphatase required for transcription by RNA polymerase II and CTD dephosphorylation in S. cerevisiaeM S Kobor, J Archambault, W Lester, et al.
Journal of Clinical Pharmacology|April 29, 1998
Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavirL L von Moltke, D J Greenblatt, J M Grassi, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequencesD J Greenblatt, C E Wright, L L von Moltke, et al.
Psychopharmacology|January 7, 1999
Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazoleL L von Moltke, D J Greenblatt, J S Harmatz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the ratTsutomu Kotegawa, Bart E Laurijssens, Lisa L Von Moltke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Phase I study of temsirolimus in pediatric patients with recurrent/refractory solid tumorsSheri L Spunt, Stephan A Grupp, Terry A Vik, et al.
Pageof 88

Showing results (841-850 of 874) with videos related to

Sort By:
Pageof 88
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1983
In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distributionR M Arendt, D J Greenblatt, R H deJong, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Alprazolam-ritonavir interaction: implications for product labelingD J Greenblatt, L L von Moltke, J S Harmatz, et al.
Neurology|April 1, 1983
Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactionsT R Browne, R G Feldman, R A Buchanan, et al.
Molecular Cell|August 13, 1999
An unusual eukaryotic protein phosphatase required for transcription by RNA polymerase II and CTD dephosphorylation in S. cerevisiaeM S Kobor, J Archambault, W Lester, et al.
Journal of Clinical Pharmacology|April 29, 1998
Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavirL L von Moltke, D J Greenblatt, J M Grassi, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequencesD J Greenblatt, C E Wright, L L von Moltke, et al.
Psychopharmacology|January 7, 1999
Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazoleL L von Moltke, D J Greenblatt, J S Harmatz, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the ratTsutomu Kotegawa, Bart E Laurijssens, Lisa L Von Moltke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2011
Phase I study of temsirolimus in pediatric patients with recurrent/refractory solid tumorsSheri L Spunt, Stephan A Grupp, Terry A Vik, et al.
Pageof 88